Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals (AMPH) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 01'st May 2024
Amphastar (AMPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
04:05pm, Tuesday, 30'th Apr 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, a
Why Amphastar (AMPH) Could Beat Earnings Estimates Again
01:11pm, Tuesday, 30'th Apr 2024
Amphastar (AMPH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
New Strong Sell Stocks for April 26th
07:46am, Friday, 26'th Apr 2024
AMPH, BCML and DHC have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2024.
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
06:00am, Monday, 01'st Apr 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations,
Is Amphastar (AMPH) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Wednesday, 27'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
06:56pm, Tuesday, 26'th Mar 2024
The latest trading day saw Amphastar Pharmaceuticals (AMPH) settling at $43.21, representing a -0.96% change from its previous close.
New Strong Sell Stocks for March 18th
10:15am, Monday, 18'th Mar 2024
ACNB, AMPH and TRDA have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2024.
Brokers Suggest Investing in Amphastar (AMPH): Read This Before Placing a Bet
10:31am, Monday, 11'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
04:05pm, Wednesday, 06'th Mar 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / March 6, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, EVP of Regulatory Affairs and Clinical Operation
Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions
01:37pm, Monday, 04'th Mar 2024
Amphastar Pharmaceuticals specializes in developing, manufacturing, and distributing pharmaceutical products, with a focus on strategic acquisitions. The company's portfolio includes high-margin produ
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript
07:46pm, Thursday, 29'th Feb 2024
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
06:26pm, Wednesday, 28'th Feb 2024
Amphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.87 per share. This compares to earnings of $0.73 per share a year ago.
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
04:05pm, Wednesday, 28'th Feb 2024
Reports Net Revenues of $178.1 Million for the Three Months Ended December 31, 2023 RANCHO CUCAMONGA, CA / ACCESSWIRE / February 28, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" o
Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know
06:45pm, Thursday, 22'nd Feb 2024
In the closing of the recent trading day, Amphastar Pharmaceuticals (AMPH) stood at $51.91, denoting a +1.29% change from the preceding trading day.
